|
|
|
| Modern progress of clear cell adenocarcinoma of the cervix |
| HU Xiaodi WU Yumei |
| Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, China |
|
|
|
Abstract Cervical clear cell carcinoma (CCAC) is a rare cervical malignancy. The treatment of CCAC is based on the clinical stages of the patients and their desire to have children. This article reviews the etiology, clinical manifestations, treatment and prognosis of CCAC.
|
|
|
|
|
|
[1] Jemal A，Bray F，Center M，et al. Global Cancer Statistics [J]. Clin， 2015，6（1）：69-90.
[2] 国家癌症中心.2018年全国最新癌症报告[Z].2018.
[3] Pal S，Jana S，Bose K. Clear Cell Carcinoma of Cervix in a Postmenopausal Woman：A Case Report [J]. J Midlife Health，2015，6（2）：85-87.
[4] Huo D，Anderson D，Palmer JR，et al. Incidence Rates and Risks of Diethylstilbestrol-Related Clear-Cell Adenocarcinoma of the Vagina and Cervix：Update after 40-Year Follow-Up [J]. Gynecol Oncol，2017，146（3）：566-571.
[5] Herbst AL，Ulfelder H，Poskanzer DC. Adenocarcinoma of the Vagina：Association of Maternal Stilbestrol Therapy with Tumor Appearance in Young Women [J]. N Engl J Med，1971，284（15）：878-881.
[6] Hasegawa K，Nagao S，Yasuda M，et al. Gynecologic Cancer InterGroup （GCIG） Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix [J]. Int J Gynecol Cancer，2014，24（9）：90-95.
[7] Chaloob MK，Hussein AG，Qasim BJ，et al. Correlation of P16 （Ink4a） and CK17 to HPV （16E6+18E6） in Premalignant and Malignant Lesions of Uterine Cervix：A Clinicopathologic Study [J]. Iran J Pathol，2016，11（4）：377-390.
[8] Kocken M，Baalbergen A，Snijders PJ，et al. High-Risk Human Papillomavirus Seems Not Involved in DES-Related and of Limited Importance in NonDES Related Clear-Cell Carcinoma of the Cervix [J]. Gynecol Oncol，2011， 122（2）：297-302.
[9] Jiang X，Jin Y，Li Y，et al. Clear Cell Carcinoma of the Uterine Cervix：Clinical Characteristics and Feasibility of Fertility-Preserving Treatment [J]. Oncol Targets Ther，2014， 9（7）：111-116.
[10] Smith EK，White MC，Weir HK，et al. Higher Incidence of Clear Cell Adenocarcinoma of the Cervix and Vagina among Women Born between 1947 and 1971 in the United States [J]. Cancer Causes Control，2012，23（1）：207-211.
[11] Arora A，Rastogi A，Neyaz A，et al. Clear Cell Adenocarcinoma of Cervix in 1-year-old Girl without in Utero Exposure to Diethylstilbestrol：An Uncommon Tumour at an Uncommon Age and Site [J]. BMJ Case Rep，2017:bcr20 16218730.
[12] Paramita S，Soewarto S，Widodo MA，et al. High Parity and Hormonal Contraception Use as Risk Factors for Cervical Cancer in East Kalimantan [J]. Medical Journal of Indonesia，2010，19（4）：268-272.
[13] 蒋艳，陈建琼，毛熙光.宫颈透明细胞癌的诊治进展[J].西南军医，2013，1（2）：174-177.
[14] 涂云霞，胡小青，华金仁.宫颈透明细胞癌50例临床病例分析[J].现代肿瘤医学，2017，25（10）：1609-1612.
[15] 汪海丹.高危型HPV检测及TCT检查在宫颈癌筛查中的应用探讨[J].母婴世界，2018（6）：54.
[16] Hanselaar A，van Loosbroek M，Schuurbiers O，et al. Clear Cell Adenocarcinoma of the Vagina and Cervix. An update of the central Netherlands registry showing twin age incidence peaks [J]. Cancer，1997，79（11）：2229-2236.
[17] Hanselaar AG，Boss EA，Massuger LF，et al. Cytologic Examination to Detect Clear Cell Adenocarcinoma of the Vagina or Cervix [J]. Gynecol Oncol，1999，75（3）：338-344.
[18] Yang L，Zheng A，Zhang X，et al. Clear Cell Carcinoma of the Uterine Cervix：A Clinical and Pathological Analysis of 47 Patients Without Intrauterine Diethylstilbestrol Exposure [J]. Int J Gynecol Cancer，2017，27（5）：1009-1014.
[19] Baykara M，Benekli M，Erdem O，et al. Clear Cell Adenocarcinoma of the Uterine Cervix：A Case Report and Review of the Literature [J]. J Pediatr Hematol Oncol，2014，36（2）：e131-e133.
[20] Ju B，Wang J，Yang B，et al. Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma [J]. Int J Gynecol Pathol，2018， 37（4）：388-396.
[21] Hashiguchi M，Kai K，Nishiyama S，et al. Clear Cell Carcinoma of the Uterine Cervix Presented as a Submucosal Tumor Arising in a Background of Cervical Endometriosis [J]. Int J Gynecol Pathol，2018，37（1）：88-92.
[22] Jiang X，Jin Y，Li Y，et al. Clear Cell Carcinoma of the Uterine Cervix：Clinical Characteristics and Feasibility of Fertility-preserving Treatment [J]. Oncol Targets Ther，2014，7：111-116.
[23] Herbst AL，Norusis MJ，Rosenow PJ，et al. An Analysis of 346 Cases of Clear Cell Adenocarcinoma of the Vagina and Cervix with Emphasis on Recurrence and Survival [J]. Gynecol Oncol，1979，7（2）：111-122.
[24] Matthews KS，Numnum TM，Conner MG，et al. Fertility-sparing radical abdominal trachelectomy for clear cell adenocarcinoma of the upper vagina：A case report [J]. Gynecol Oncol，2007，105（3）：820-822.
[25] Pareja R，Rendón GJ，Sanz-Lomana CM，et al. Surgical，Oncological，and Obstetrical Outcomes after Abdominal Radical Trachelectomy-A Systematic Literature Review [J]. Gynecol Oncol，2013，131（1）：77-82.
[26] Reich O，Tamussino K，Lahousen M，et al. Clear Cell Carcinoma of the Uterine Cervix：Pathology and Prognosis in Surgically Treated Stage ⅠB-ⅡB Disease in Women Not Exposed in Utero to Diethylstilbestrol [J]. Gynecol Oncol，2000，76（3）：331-335.
[27] Thomas MB，Wright JD，Leiser AL，et al. Clear Cell Carcinoma of the Cervix：A Multi-Institutional Review in the Post-DES Era [J]. Gynecol Oncol，2008，109（3）：335-339.
[28] 林玲，陈桂林，陈炜.宫颈透明细胞癌19例临床特征及生存分析[J].福建医药杂志，2017，39（5）：32-34.
[29] 蒋湘，金滢，李艳.宫颈透明细胞癌28例临床分析[J].基础医学与临床，2013，33（3）：264-269.
[30] 王子毅.宫颈透明细胞癌11例临床分析[A].中国医师协会肿瘤医师分会、中国抗癌协会肿瘤临床化疗专业委员会.中国肿瘤内科进展 中国肿瘤医师教育（2014）[C].中国医师协会肿瘤医师分会、中国抗癌协会肿瘤临床化疗专业委员会:中国抗癌协会,2014:1. |
|
|
|
